The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer. (January 2019) - Elmushraf, R.; Clinch, H.; Salawu, A.; Fisher, P.; Young, R.; Lee, C.; Danson, S.; Bates, E.; Hatton, M.; Low, L.; Das, T.; Taylor, F.